Dr Anna Kozmenko is a partner in Schellenberg Wittmer’s dispute resolution group in Zurich. She represents states, state-owned and private companies as well as individuals in high profile international disputes, including complex litigations, commercial and investment arbitrations as well as sports disputes. She also regularly sits as arbitrator.
Anna’s experience includes over 70 arbitrations, both ad hoc and institutional (under the ICC, LCIA, SCC, VIAC, AAA/ICDR, DIS, ICAC, CAS, UNCITRAL, PCA, ICSID, ICSID Additional Facility and Swiss rules), at various seats and under a broad range of applicable laws.
Anna’s recent notable matters include: representation of the Russian Federation in several investment arbitration matters and set aside proceedings before the Swiss Supreme Court; representation, before the CAS, of 39 athletes who had been wrongly banned for life from the Olympic Games amid allegations of a systematic doping scheme around the Sochi Olympic Games; representation of the Russian Antidoping Agency in a dispute against the World Anti-Doping Agency; and the successful defense of GazpromNeft PJSC before a Swiss court against the European Bank for Reconstruction and Development.
Anna is an adjunct professor of law at the University of Arkansas School of Law, where she teaches international commercial arbitration. She is also a visiting Lecturer at the Lomonosov Moscow State University, the Moscow State Institute of International Relations, and the National Research University Higher School of Economics. She was, until recently, co-chair of ICDR Young & International. Anna was named as “top arbitration practitioner” by the Russian Arbitration Association every year from 2014 to 2018.
Prior to joining Schellenberg Wittmer, Anna practiced at a leading international law firm in Paris and New York. She graduated with the highest honours from Peoples’ Friendship University of Russia (BA, MA and doctorate degrees) and obtained an LL.M. degree in international dispute settlement from the University of Geneva (MIDS).